Analysts/Institutional Investor Meet/Con. Call Updates

Date:14th August, 2026 To, To, Manager - Listing Compliance Head of the Department, National Stock Exchange of India Limited Department of Listing Operation, ‘Exchange Plaza’. C-1, Block G, BSE Limited Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers, Mumbai - 400 051 Dalal Street, Mumbai 400001 SYMBOL: JSLL SCRIP Code: 544476 Subject: Intimation to Stock Exchange –Submission of Transcript of Earnings Conference Call for the quarter ended June 30, 2026. Dear Sir/Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we hereby inform you that the transcript of the Earnings Conference Call held on Monday, August 10, 2026, to discuss the Unaudited Financial Results of the Company for the quarter (Q1 FY 26-27) ended June 30, 2026, has been made available on the website of the Company. The transcript of the aforesaid Earnings Conference Call can be accessed at the following link: https://jeenasikho.com/wp-content/uploads/2026/08/Jeena-Sikho-Q1FY27-Earning-Call-Transcript.pdf Kindly take the above intimation on your record. Thanking you, Yours faithfully, For Jeena Sikho Lifecare Limited Manish Grover Managing Director DIN: 07557886 Place: Zirakpur, Punjab Date: 14.08.2026 Encl: A/A “Jeena Sikho Lifecare Limited Q1 FY27 Earnings Conference Call” August 10, 2026 MANAGEMENT: MR. MANISH GROVER – MANAGING DIRECTOR – JEENA SIKHO LIFECARE LIMITED MR. ANKUSH KAUSHAL – WHOLE-TIME DIRECTOR – JEENA SIKHO LIFECARE LIMITED MR. NANAK CHAND – CHIEF FINANCIAL OFFICER – JEENA SIKHO LIFECARE LIMITED MODERATOR: MS. SOUMYA CHHAJED – GO INDIA ADVISORS Page 1 of 22 Jeena Sikho Lifecare Limited August 10, 2026 Moderator: Ladies and gentlemen, good day and welcome to Jeena Sikho Lifecare Limited Q1 FY27 Earnings Conference Call, hosted by Go India Advisors. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing '*' then '0' on your touchtone phone. I now hand the conference over to Ms. Soumya Chhajed from Go India Advisors. Thank you and over to you, ma'am. Soumya Chhajed: Good day everyone and welcome to the Q1 FY27 conference call of Jeena Sikho Lifecare Limited. We have on call with us Mr. Manish Grover-ji, Managing Director; Mr. Ankush Kaushal, Whole-Time Director; and Mr. Nanak Chand, Chief Financial Officer. We must remind you that discussions on today's call may include certain forward-looking statements and must therefore be viewed in conjunction with the risks pertaining to the business. I now request the management to take us through the business update, and post that, we will open the floor for Q&A. Thank you, and over to you, sir. Manish Grover: Hello, everyone. First of all, I would like to thank all investors, analysts, and stakeholders who have spared their time for today's earnings call. Each quarter's results are not just a story of numbers, but they also reflect the direction in which the business is moving, the strength of its underlying strategy, and how strong a foundation is being built for the coming years. Today, healthcare is passing through a crucial transition phase. Until now, most of the focus in healthcare has been on treatment after a disease occurs. However, we believe that in the coming times, the biggest opportunity in healthcare will be in prevention. While we have heard the proverb 'prevention is better than cure' since childhood, I say that 'prevention is the only cure.' Preventing a disease before it occurs is far better than treating it after it arrives, and this forms the foundation of Jeena Sikho's philosophy. Our focus is not just on lifespan, but on healthspan—that is, not just how many years a person lives, but how many years they remain healthy and active. Our business model executes this philosophy at the ground level. A patient's journey does not necessarily start with a hospital admission; an individual can enter our ecosystem through health awareness initiatives or health camps. Subsequently, engagement grows through consultations, OPD, lifestyle coaching, products, and longevity guidance. Where intensive treatment is required, this same journey moves towards our hospitals, wellness IPD, and treatment, where we provide care through Panchakarma and Ayurvedic treatment protocols. Crucially, a patient's relationship does not end with discharge. Post-treatment follow-ups, lifestyle guidance, and Ayurvedic medicines keep the patient engaged in our ecosystem. Through this, an IPD patient can become a recurring product customer in the future. Similarly, in the other direction, customers and OPD-connected individuals who feel the need for intensive treatment can become IPD patients in our hospitals. Thus, services and products are not two separate businesses for us; both serve as sources of demand and engagement for each other. The most critical part of this entire model is trust. When a patient receives clinical outcomes, they feel satisfied with their experience, and that experience becomes a word-of-mouth driver Page 2 of 22 Jeena Sikho Lifecare Limited August 10, 2026 and a channel for new patient acquisition for us. Over time, this strengthens customer relationships and improves acquisition economics. In Q1 FY27, the execution of this model is reflected in our financial performance. In this quarter, our revenue from operations stood at INR224 crores, while EBITDA was INR92 crores and PAT was INR65 crores. We delivered a 41% EBITDA margin and a 28% PAT margin. These numbers do not merely show a single quarter's performance, but also reflect the strength of the operating model that we have built with scale. Our next phase is not limited to physical expansion alone. We want to make technology a key component of the preventive healthcare journey, and our long-term vision lies in this direction. As I have stated before, do not judge us on a quarter-on-quarter basis; judge us according to an annual system, because we are developing a massive ecosystem whose reflection will be visible in the next 2 to 3 years. Over the long term, Jeena Sikho aims to build a health operating system where awareness, consultation, treatment, products, continuous preventive care, an integrated ecosystem, and wellness are all available under one roof for an individual. We believe the next big opportunity in healthcare is not just in treating more patients, but in staying connected with people for a longer duration and keeping them healthy. That is why we are launching a model where patients will continue to visit for Panchakarma and regular day care at a recurring level. With this vision, we are continuously investing in our network, clinical capabilities, technology, and product ecosystem. We believe that a prevention-first approach, strong execution, and disciplined capital allocation will position Jeena Sikho to create meaningful long-term value for all stakeholders in the coming years. In conclusion, our thinking is very simple: treating diseases is one part of healthcare, but keeping people healthy is the future of healthcare. That is what we are working on, and to build this future, Jeena Sikho is working at a rapid pace day and night. With this, I now invite our CFO, Mr. Nanak Chand, to provide detailed financial performance details for Q1 FY27. Thank you. Jai Hind. Nanak Chand: Thank you, Acharya Manish ji. Good afternoon, everyone. I will walk you through the financial performance. We commenced FY27 on a healthy note with both our Ayurveda healthcare services and products business delivering strong underlying performance on an annual basis. Revenue from operations grew by 29% YoY in Q1 FY27, supported by higher patient footfalls, expansion of our service netwo [Showing first 8,000 characters — download PDF for full document]